ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Regeneron Announces Phase 2 Results for Garetosmab americanpharmaceuticalreview
January 14, 2020Regeneron Pharmaceuticals announced results from LUMINA-1, a 44-patient, Phase 2, double-blind placebo-controlled trial evaluating garetosmab (REGN2477) in patients with fibrodysplasia ossificans progressiva (FOP).
Pharma Sources Insight July 2025
